SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-218633
Filing Date
2021-07-19
Accepted
2021-07-19 16:21:54
Documents
14
Period of Report
2021-07-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d194928d8k.htm   iXBRL 8-K 26077
2 EX-99.1 d194928dex991.htm EX-99.1 10875
6 GRAPHIC g194928g0719131408331.jpg GRAPHIC 4507
  Complete submission text file 0001193125-21-218633.txt   170724

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20210719.xsd EX-101.SCH 2916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20210719_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20210719_pre.xml EX-101.PRE 11424
7 EXTRACTED XBRL INSTANCE DOCUMENT d194928d8k_htm.xml XML 3418
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 211098138
SIC: 2834 Pharmaceutical Preparations